The aspirin users in subgroup analysis had lower competing adjusted risk for PLA recurrence after a first episode of PLA; this was especially significant for females, those with diabetes or a non-cancer comorbidity, amoxicillin and ampicillin non-users, other anti-diabetic drug non-users, and insulin non-users (Fig. S1). The gene discussed is INS; the disease is cancer.